fda compounding restrictions bpc-157 Approval Status: Is It Approved for Human Use? FDA to Consider Lifting Restrictions

Bertinato 2015

Lipidomics of human brain aging and Alzheimers disease pathology

GHK-Cu demonstrates activity at higher absolute doses than the other two components

Understanding the 503A Bulks List Section 503A of the Federal Food, Drug, and Cosmetic Act sets the conditions that must be met for a compounded drug product to be exempt from three key federal requirements: current good manufacturing practice standards, labeling with adequate directions for use, and approval under a new drug application

It's the single largest determinant of whether the protocol works

The serum needs to make contact with your scalp, not coat every strand of hair